These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 41197)

  • 1. Dopaminergic antagonism of L-5-hydroxytryptophan-induced myoclonic jumping behavior.
    Weiner WJ; Carvey PM; Nausieda PA; Klawans HL
    Neurology; 1979 Dec; 29(12):1622-5. PubMed ID: 41197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of 5-hydroxytryptaminergic antagonists upon apomorphine- and lergotrile-induced hypothermia and stereotyped behaviour in rats.
    Wade RL; Quock RM; Malone MH
    J Pharm Pharmacol; 1984 Oct; 36(10):673-6. PubMed ID: 6150084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term suppression of central serotonergic activity by corticosteroids: a possible model of steroid-responsive myoclonic disorders.
    Nausieda PA; Carvey PM; Braun A
    Neurology; 1982 Jul; 32(7):772-5. PubMed ID: 6979722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of the central dopaminergic stimulants apomorphine and lergotrile.
    Wade RL; Krewsun I; Quock RM
    Proc West Pharmacol Soc; 1979; 22():141-2. PubMed ID: 42079
    [No Abstract]   [Full Text] [Related]  

  • 5. L-5-HTP-induced myoclonic jumping behavior in guinea pigs: an update.
    Carvey P; Paulseth JE; Goetz CG; Klawans HL
    Adv Neurol; 1986; 43():509-17. PubMed ID: 3484857
    [No Abstract]   [Full Text] [Related]  

  • 6. The specificity of neuroleptic- and methysergide-induced behavioral hypersensitivity.
    Klawans HL; D'amico DJ; Nausieda PA; Weiner WJ
    Psychopharmacology (Berl); 1977 Nov; 55(1):49-52. PubMed ID: 414261
    [No Abstract]   [Full Text] [Related]  

  • 7. Blockade of lergotrile or apomorphine induced turning behavior by haloperidol and clozapine.
    Nakamura S; Engel J; Goldstein M
    Commun Psychopharmacol; 1978; 2(3):185-90. PubMed ID: 29742
    [No Abstract]   [Full Text] [Related]  

  • 8. Clonazepam and 5-hydroxytryptophan-induced myoclonic stereotypy.
    Weiner WJ; Goetz C; Nausieda PA; Klawans HL
    Eur J Pharmacol; 1977 Nov; 46(1):21-4. PubMed ID: 303572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the interaction of reserpine, d-amphetamine, apomorphine and 5-hydroxytryptophan.
    Goetz C; Klawans HL
    Acta Pharmacol Toxicol (Copenh); 1974 Aug; 35(2):119-30. PubMed ID: 4547506
    [No Abstract]   [Full Text] [Related]  

  • 10. Modification of central serotonergic and dopaminergic behaviors in the course of chronic corticosteroid administration.
    Nausieda PA; Carvey PM; Weiner WJ
    Eur J Pharmacol; 1982 Mar; 78(3):335-43. PubMed ID: 6978254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral supersensitivity to 5-hydroxytryptophan induced by chronic methysergide pretreatment.
    Klawans HL; D'Amico DJ; Patel BC
    Psychopharmacologia; 1975 Nov; 44(3):297-300. PubMed ID: 1082146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of chronic treatments with SM-9018, a potential atypical neuroleptic, on behavioral dopaminergic and serotonergic sensitivities in rats.
    Ohno Y; Ishida K; Ishibashi T; Ikeda K; Kato T; Nakamura M
    Gen Pharmacol; 1995 May; 26(3):489-94. PubMed ID: 7789721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some central pharmacological effects of the calcium channel antagonist flunarizine.
    Czyrak A; Mogilnicka E; Maj J
    J Neural Transm Gen Sect; 1991; 83(3):179-88. PubMed ID: 2031709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonergic and antiserotonergic influences on apomorphine-induced stereotyped behaviour.
    Weiner WJ; Goetz C; Klawans HL
    Acta Pharmacol Toxicol (Copenh); 1975 Feb; 36(2):155-60. PubMed ID: 1079682
    [No Abstract]   [Full Text] [Related]  

  • 15. Tonic immobility: effects of dopamine receptor blockade and stimulation.
    Wallnau LB; Carnrike CL; Dewey GI
    Pharmacol Biochem Behav; 1979 Feb; 10(2):177-81. PubMed ID: 572054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levodopa-induced myoclonus.
    Klawans HL; Goetz C; Bergen D
    Arch Neurol; 1975 May; 32(5):330-4. PubMed ID: 1079721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioural effects of drugs acting on the central dopaminergic neurons.
    Georgiev V; Markovska V
    Act Nerv Super (Praha); 1977 Jul; 19 Suppl 2():335-6. PubMed ID: 575925
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential alteration in striatal dopaminergic and cortical serotonergic receptors induced by repeated administration of haloperidol or centbutindole in rats.
    Gulati A; Srimal RC; Dhawan BN
    Pharmacology; 1988; 36(6):396-404. PubMed ID: 2901759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dopaminergic drugs on phencyclidine-induced behavior in the rat.
    Castellani S; Adams PM
    Neuropharmacology; 1981 Apr; 20(4):371-4. PubMed ID: 7197334
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of dopaminergic agonists upon body temperature and behavior of spontaneously hypertensive and normotensive rats.
    Martin JR; Quock RM
    Proc West Pharmacol Soc; 1978; 21():451-3. PubMed ID: 567806
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.